Emerging studies suggest Retatru tide , a dual activator targeting both GLP-1 and GIP , may represent a significant advancement for body loss . Preliminary human investigations have shown considerable reductions in abdominal tissue, conceivably outperforming current body composition treatments. However , further evaluation is necessary to completel